Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1164/rccm.201801-0199IM | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Outcomes of surgical management of carcinoid heart disease in patients with primary gonadal neuroendocrine tumors.
JTCVS Open
August 2025
Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minn.
Objectives: To describe the clinical presentation of patients with gonadal neuroendocrine tumors and carcinoid heart disease (CaHD) and to evaluate long-term outcomes following valvular surgery.
Methods: Retrospective review of patients with primary gonadal neuroendocrine tumor who were surgically treated for CaHD at our institution between 1990 and 2021.
Results: Eight patients (median age, 70 years) were included in the study, 7 with ovarian tumors and 1 with testicular tumor.
Surgical management of both stage III and stage IV pulmonary carcinoid tumors confers survival benefit.
JTCVS Open
August 2025
Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, Ariz and Rochester, Minn.
Objective: Pulmonary carcinoid tumors are an uncommon entity, with an incidence of 1.35 cases per 100,000 individuals. Although decisions about surgical resection are commonly made similarly to those for non-small cell lung cancer, data surrounding the optimal treatment and prognostication for patients with advanced disease are limited.
View Article and Find Full Text PDFCLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY.
Endocr Relat Cancer
September 2025
Endocrinology, Diabetology and Medical Andrology Unit, IRCCS, Humanitas Research Hospital, Rozzano, Milan, Italy.
Bone metastases (BMs) are rare and late event in patients with neuroendocrine tumors (NETs). The aim of our study was to investigate clinical presentation and outcome of BMs in a large cohort of patients with NETs. A retrospective study was performed at two referral centers of Northern Italy (IRCCS Humanitas Research Hospital in Milan and S.
View Article and Find Full Text PDFCase Report: Rare multisystem metastasis in head and neck paraganglioma with pathogenic variant and VUS manifested as FUO.
Front Endocrinol (Lausanne)
September 2025
Department of Infectious Disease, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Background: Paragangliomas (PGLs) are rare neuroendocrine tumors originating from the extra-adrenal autonomic paraganglia with a strong genetic background. pathogenic variants are associated with the highest rate of malignancy in PGLs. Most head and neck paragangliomas (HNPGs) are asymptomatic and benign, and multiple metastases are rare.
View Article and Find Full Text PDF[Neuroendocrine cell hyperplasia of infancy].
Ugeskr Laeger
September 2025
H.C. Andersen Børne- og Ungehospital, Odense Universitetshospital.
This case report describes two infants with persistent tachypnea, retractions, hypoxemia during sleep, and failure to thrive. After excluding common causes, high-resolution CT revealed ground-glass opacities in the lingula and perihilar regions. The infants were diagnosed with NEHI, and their treatment was mainly supportive.
View Article and Find Full Text PDF